Healthcare stocks are currently providing investors with an attractive way to counterbalance a portfolio overexposed to tech. In general, healthcare stocks have lower betas, are more defensive, and ha

3 Cheap Dividend Stocks to Buy In April

09:15am, Wednesday, 05'th Apr 2023
Verizon Communications has a low payout ratio and an attractive yield of nearly 7%. American Express gives investors a decent yield along with some good growth prospects.

Final Trades: PFE, QQQ, TSLQ & GOLD

07:00pm, Tuesday, 04'th Apr 2023
The final trades of the day. With CNBC's Melissa Lee and the Fast Money traders.

4 Dividend Stocks Top Managers Are Buying

08:00am, Tuesday, 04'th Apr 2023
#Morningstar  #PfizerStock #StockPicks These stocks were among the purchases of several of our Ultimate Stock-Pickers last quarter. 00:00 Introduction 00:22 Pfizer (PFE) 1:04 Pioneer Natural Resourc
In these tumultuous times, with markets facing substantial headwinds from yet another financial crisis, savvy investors are on the lookout for safe havens. Perhaps the best refuge is in undervalued di
While it's always good to have decent exposure to investments yielding passive income, you also want to consider reliable dividend stocks with low-payout ratios. By that, I'm referring to enterprises

High Yield Stock Watchlist: April 2023

04:04pm, Monday, 03'rd Apr 2023
There are 19 stocks on my high-yield watchlist for April 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.

7 Stocks About to Soar as Fed Rate Hikes Pause

04:18pm, Sunday, 02'nd Apr 2023
The Federal Reserve instituted its ninth consecutive rate hike just a few days ago, roiling stocks and markets. The 25 basis point increase was in question, though, as banking turmoil led many to beli
It's too early to say the market has turned the corner, but some analysts suggest that equities could be at the beginning of a bull market. The banking crisis appears to be contained.

3 Surprisingly Underrated Stocks to Buy in April

06:14am, Saturday, 01'st Apr 2023
Axsome Therapeutics has multiple catalysts on the way. Johnson & Johnson is a bargain with its improving growth prospects.

Pfizer: Don't Bank On mRNA Vaccines

12:55am, Saturday, 01'st Apr 2023
A huge increase in cost may reduce demand. Contradictory evidence on efficacy and safety may be a concern moving forward.
Fortune Magazine February/March 2023 Issue listed 50 World's Most Admired (WMA) companies based on a poll of "some 3,760 corporate executives, directors, and securities analysts." Acclaim from the wid
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
NASH, or nonalcoholic steatohepatitis, is a liver inflammatory disease that can progress to fibrosis and cirrhosis. NASH is now the second leading cause of liver transplantation, and the US patient po
Blue chip dividend stocks rarely trade at a discount. Gilead Sciences and Pfizer are two exceptions to this general rule of thumb.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE